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Feature Article
Developmental origins of health and disease:
current knowledge and potential mechanisms
5
Daniel J. Hoffman, Rebecca M. Reynolds, and Daniel B. Hardy
Epidemiologic and clinical research has provided a large body of evidence support-
ing the developmental origins of health and disease (DOHaD), but there has been
10 a relative dearth of mechanistic studies in humans due to the complexity of work-
ing with large, longitudinal cohorts. Nonetheless, animal models of undernutrition
have provided substantial evidence for the potential epigenetic, metabolic, and en-
docrine mechanisms behind DOHaD. Furthermore, recent research has explored the
interaction between the environment and the gastrointestinal system by investigat-
15 ing how the gut microbial ecology may impact the capacity for nutrient processing
and absorption in a manner that may limit growth. This review presents a sum-
mary of current research that supports the concept of DOHaD, as well as potential
mechanisms and interactions that explain how nutrition in utero and during early
childhood influences lifelong health.
20 INTRODUCTION
Human health, often defined as the absence of disease, is
determined by a number of factors related to diet, envi-
ronment, and economics, as well as country of residence
and educational attainment. The confluence of these
25 areas highlights the interplay of both biological and so-
cioeconomic factors that ultimately allow for normal de-
velopmental processes to occur and optimal health
during the life of a human. Over the past 30 years, sub-
stantial attention has been given to the influence of nutri-
30 tion in utero and during critical periods of growth on
health in adulthood, an area termed the “fetal origins
hypothesis” or “fetal programming”; it was later modified
to the “developmental origins of health and disease”
(DOHaD) to better reflect both the gestational and post-
35 natal periods. Beginning with the work of Barker and
Osmond in 1986,1 it was documented that chronic
diseases commonly associated with higher income had
become more prevalent in lower-income regions of
England and Wales. Thereafter, a number of studies
40were conducted using the Hertfordshire birth cohort,
which included more than 15 000 babies for whom birth
weight and early feeding practices were documented in
the early part of the 20th century.2 From this cohort, it
was shown that children born small are at a higher risk
45for developing type 2 diabetes (T2D), hypertension, and
coronary heart disease.2–4 Similar results have been pub-
lished using birth cohorts from South Africa, Finland,
the United States, Brazil, and China, among others.5–9
However, a consistent challenge to human cohort studies
50has been the elucidation of clear physiological or envi-
ronmental mechanisms behind the findings.
Early epidemiological research of DOHaD used
data from several well-documented famines and histori-
cal cohorts (Table 11–4,6–18). Among these, the most
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well known is the Dutch famine cohort, which included
men and women born before, during, and after the
Nazi-imposed famine of 1944–1945.10 Adults who were
exposed to the famine during mid or late gestation were
5 reported to have lower glucose tolerance compared with
those exposed early in gestation or never exposed to the
famine.10 Additionally, adults who had been exposed to
famine during any 10-week period of gestation were al-
most 3 times more likely to have hypertension than
10 unexposed adults.11 In China, adults who were exposed
in utero to the Chinese famine of 1958 had a 50% in-
creased risk for T2D compared with those not exposed
to famine.12 It was also reported that adults exposed to
the famine in utero were almost 4 times more likely to
15 have hypertension than those who had postnatal expo-
sure to the famine.13 Consistent with these studies,
adults who experienced gestational exposure to famine
in Bangladesh and remained underweight as adults
were more likely to be hyperglycemic compared with
20 unexposed adults.14 Finally, in terms of mortality, Utah
pioneers whose mothers were pregnant during periods
of severe food shortages in the mid-19th century were
found to have had a higher risk for mortality compared
with those whose mothers were not exposed, but the ef-
25 fect was most consistent for men.15 Although there are
certainly methodological differences among various
studies of famine exposure and later health, the basic
aspects of such studies are relatively consistent and al-
low for broad conclusions based on their findings.
30 In addition to the association between nutritional
deprivation early in life and risk for nutrition-related
chronic diseases, a number of studies have found a link
between poor nutrition early in life and mental health
and cognitive development. For example, prenatal expo-
35 sure to the Chinese famine from 1959 to 1961 nearly
doubled the risk of schizophrenia for those in the 1960
exposure group compared with those born after the fam-
ine16; these results are strikingly similar to the relative
risk of 2.7 for schizophrenia found in the Dutch famine
40 cohort.19 Studies from different countries have also
found that poor nutrition in childhood has a negative
impact on cognition. In Peru, stunted children (defined
as height-for-age Z score [HAZ]<2.0) scored signifi-
cantly lower (P< 0.05) on a series of cognitive tests com-
45 pared with taller children.17 Children who experienced
catch-up growth (indicating a positive change in HAZ)
had cognitive scores similar to those of children who
remained stunted.20 However, a study on growth and
cognitive performance that included more than 8000
50 children from 4 developing countries found that children
who recovered height from age 1 year to age 8 years per-
formed poorly compared with children who were never
stunted but scored better than children who remained
stunted21; this suggests that timing of nutritional
55interventions is vital to improving human capital. The
point is made even more clear by a study of stunted chil-
dren in Jamaica who received psychosocial stimulation
and scored markedly higher on IQ, verbal, and reading
tests compared with stunted children who did not receive
60such stimulation.18 Recently, as some of the children
from this cohort are now parents, it was reported that
offspring of stunted parents scored lower on a battery of
cognition tests, independent of birth weight and height-
for-age,22 but it is not clear if the effects are related to so-
65cial or biological factors. Furthermore, stunted children
in India who received nutritional supplementation for 6
months had cognitive test scores similar to those of chil-
dren who remained stunted, as well as those who recov-
ered height.23 Although the degree of stunting at age 2
70years has been shown to be related to consistent and
long-term cognitive deficits, such deficits in a cohort
from Cebu, Philippines, declined by age 11 years.24 The
studies reviewed herein indicate that the timing of inter-
ventions is clearly critical to the overall impact of nutri-
75tion on brain development during gestation and
childhood, an area of research that warrants much
greater attention to improve human capital throughout
the world, but especially in lower-income countries.
In summary, a large number of studies provide evi-
80dence that supports the concept of DOHaD. Most stud-
ies that used data from famine and longitudinal cohorts
have found that poor nutrition and/or growth during
the “first 1000 days” are risk factors for a number of
chronic diseases later in life. Exactly how and when dif-
85ferent tissue and organ systems are influenced by nutri-
ent deprivation remain major research questions, but
new studies are providing intriguing insights into po-
tential mechanisms behind DOHaD. It is important to
consider how conflicting studies can inform the re-
90search community in a way that shapes future research
designs and agendas. To facilitate such considerations,
this review explores recent research on early nutrition
and body composition with links to chronic diseases,
how maternal undernutrition influences adipose tissue
95depots and dyslipidemia, the role of glucocorticoid ex-
posure in utero and in adult health, and potential mech-
anisms that explain how poor nutrition in utero and
during childhood influences disease risk in adulthood.
OBESITY AND BODY COMPOSITION
100Nutritional deficits from conception through early child-
hood that result in individuals being born small for ges-
tational age (SGA) or growth retarded are associated
with adult obesity.25–30 This has been covered thoroughly
in a review of studies with similar and conflicting conclu-
105sions by Yu et al,31 and results from such studies are
summarized in Table 2.5,26,32–34,36–38,40–44 Briefly, one of
Nutrition ReviewsVR Vol. 00(0):1–20 3
the first studies of gestational famine exposure and obe-
sity showed that men from the Dutch famine cohort who
were exposed to famine during the first 2 trimesters of
110gestation were more likely to be obese than those ex-
posed during late gestation and early infancy.32 Similarly,
the prevalence of obesity was greater for women who
were exposed to the Chinese famine in utero than for
those who were not exposed to the famine.5 Eriksson
115et al.33 reported a U-shaped relationship between birth
weight and body mass index (BMI) such that adults born
weighing < 2500 g or > 3500 g were more likely to be
classified as obese than those born weighing between
2500 g and 3500 g. In a study of 18 000 Swedish women,
120those born small or large (< 2500 g or  4000 g) had a
higher BMI than women born with a “normal” weight.34
There may even be transgenerational effects of famine
exposure on obesity and health as offspring of women
from the Dutch famine cohort were born with a higher
125ponderal index and were almost twice as likely as off-
spring of women unexposed to the famine to report
“poor health” as adults.35 It is important to view the to-
tality of these results in light of the fact that BMI was of-
ten used as the index for adiposity. It is well known that
130BMI is an imperfect tool outside of screening for obesity,
and clinical studies that assess body composition and
body fat distribution are often more helpful in elucidat-
ing the effect of early nutrition on adult body
composition.
135It is also well recognized that birth size reflects only
1 dimension of growth and the postnatal period may
play an equal, if not greater, role in overall growth and
adult health such that the rate of growth, assessed as
change in BMI Z score (BMIZ), or rate of weight gain is
140predictive of adult BMI or body composition.36 Perhaps
the most novel study developed to address growth pat-
terns, as well as social and biological factors influencing
growth and development, is the Birth to 20 (Bt20) co-
hort study.6 Briefly, 3200 babies were recruited at birth
145in Soweto, Johannesburg, South Africa in the early
1990s and underwent measures of body composition,
growth, and socioeconomic indicators. Postnatal
growth patterns (rate of weight or length gain) were
used to differentiate between size at birth and/or growth
150as a risk factor for outcomes studied. In the Bt20 cohort,
birth weight and weight gain were not associated with
negative lipid profiles when adjusted for linear growth
from birth to 4 years.6 However, rapid gain of height
and weight from birth were associated with being over-
155weight in adolescence.40 Furthermore, rapid weight
gain early in life was associated not only with increased
adult adiposity but also early menarche, a known risk
factor for metabolic disorders and some forms of can-
cer.41,42 In contrast, a study of children from the United
160States with intrauterine growth retardation were found
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to have a higher waist circumference and greater insulin
resistance than children born with normal birth weight,
independent of changes in BMIZ from birth to age 10
years.43 However, a separate study showed that children
5 who experienced greater childhood weight gain had
greater fat mass, independent of birth weight, than chil-
dren who had a slower rate of weight gain.44
The interaction between birth weight and weight
gain in early childhood is highlighted in the Project
10 Viva study of US children, in which gain in BMIZ after
1 year was associated with greater adiposity, indepen-
dent of birth size.7 For all children, regardless of birth
weight, a rapid change in BMIZ from 6 months to 1
year postnatal was associated with increased insulin re-
15 sistance.7 In a separate analysis, a gain in BMIZ in the
first 6 postnatal months was associated with higher sys-
tolic blood pressure in childhood.7 Although excess
body fat alone is not pathogenic, it is related to disease
risk, and, indeed, children who were born small and
20 then grew faster than peers were more likely to be insu-
lin resistant than those born larger or those with a
slower postnatal growth rate.37 In addition to body fat-
ness, it has been reported that birth size and postnatal
growth exert independent effects on skeletal develop-
25 ment, depending on the timing of growth. For example,
being born small and remaining small through the first
year of life was associated with both smaller bones and
bones with lower mineral content in the femoral neck.38
Nutrition during gestation clearly has profound and
30 lasting effects on body size and body fat distribution, as
well as on development of metabolically active tissue,
contributing to metabolic disorders. However, different
methods of measuring body composition were used in
these studies, as were different statistical analyses, which
35 underscores the need forfuture studies to normalize
methods so esults are more comparable with existing
studies.
With regard to postnatal nutrition insults, a num-
ber of studies have found that stunting is a risk factor
40 for obesity and central adiposity. In the mid-1990s, a
study conducted in 4 countries undergoing the nutri-
tion transition found that stunting in adolescence was a
risk for obesity in adulthood.45 Many, but not all, clini-
cal studies of stunting and risk for obesity support this
45 initial finding. For example, in Senegal, adolescent girls
who were stunted before the age of 2 years were more
likely to accumulate subcutaneous fat in the trunk and
arms than nonstunted girls, even when analyses were
adjusted for BMI.46 In Guatemala, children who were
50 stunted had a BMI above the median for US children of
the same age but their level of extremity fat was low, as
assessed using skinfold measurements.47 Data from the
same cohort showed that adults who were severely
stunted as children had greater central fat, independent
55of total fat mass and other confounding factors, than
those who were moderately or never stunted.48 Stunted
children in Brazil who were studied for 4 years gained
more fat in the truncal region than children from the
same shantytowns who were not stunted.49 However,
60other studies have found different relationships. For ex-
ample, longitudinal analyses of the Bt20 cohort found
that stunting at age 2 years was not associated with a
high BMI or central adiposity.50 Also, a study of indige-
nous children in Bolivia showed that stunting was asso-
65ciated with lower BMIZ and body fatness assessed using
skinfold measurements.51 At the same time, in a
Brazilian cohort, stunting was not associated with
higher BMI or fat mass compared with children who
were of normal height.52 Although differing from other
70cohort studies, results from the Brazilian cohort, which
had a relatively low prevalence of undernutrition
(< 10%), showed that poor growth early in life resulted
in shortness later in life; while this was a predictor of
poor health outcomes and other factors associated with
75poverty, it was not a predictor of excess adiposity or
obesity. What is important to consider when these com-
plementary and conflicting results are presented is that
each study, although perhaps similar in participant
characteristics or inclusion criteria, may differ in terms
80of outcome measurements, sample size, and the socio-
economic environment in which the study sample has
grown and developed. Although investigators attempt
to control for all possible confounding factors, the inter-
actions among a large number of factors are bound to
85influence associations, thus preventing consensus on
the question being studied.
An abundance of clinical research has provided
solid evidence that poor nutrition in the “first 1000
days” has a negative impact on body composition and
90body fat distribution in ways that may increase the risk
for metabolic disorders and other chronic diseases.
Although these studies provide some insight into physi-
ological consequences of poor nutrition during critical
periods of growth and development, they still do not
95provide sufficient insight into precise mechanisms that
explain why poor growth increases the risk of various
chronic diseases. What follows is a detailed discussion
of potential metabolic and hormonal mechanisms that
support these clinical studies.
100DYSLIPIDEMIA AND IMPAIRED METABOLIC OUTCOMES
The liver and adipose are critical for proper lipid and
glucose metabolism in mammals, and impaired devel-
opment and functioning of either of these tissues results
in dyslipidemia, leading to obesity and insulin resis-
105tance and culminating in the metabolic syndrome.53,54
Given the role of the liver in cholesterol, fatty acid, and
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glucose homeostasis, it is not surprising that hepatic
dysfunction underlies several of the symptoms that
characterize the metabolic syndrome.53,54 Because adi-
pose tissue is critical to the proper storage of dietary
5 and de novo hepatic lipids, compromised adipose func-
tion can also contribute toward the dysregulation of
both lipid homeostasis and insulin sensitivity.55 In addi-
tion to the metabolic syndrome, dyslipidemia can also
lead to liver fibrosis (and the end stage, cirrhosis), a dis-
10 ease that contributes to almost 45% of all deaths in the
developed world.56,57
Clinical evidence linking maternal undernutrition and
dyslipidemia
The work of David Barker and others has now clearly
15 established that adverse in utero events can permanently
alter physiological processes, leading to dyslipidemia and
the metabolic syndrome.58 The early evidence that an
impairment of liver size and/or function was involved
with dysmetabolism came from the strong correlation
20 between reduced abdominal circumference at birth and
elevated total and low-density lipoprotein cholesterol
later in life.59 Second, intrauterine growth restriction
(IUGR), caused by either placental insufficiency or ma-
ternal malnutrition, often results in asymmetric organ
25 development, whereby there is a reduction in the growth
of less essential organs, including the liver, lungs, and
kidneys.60,61 Third, there is a strong inverse relationship
between birth weight and obesity or glucose intolerance,
which are both under the regulation of the liver.2,32,62,63
30 Altered adipose function in humans can also contribute
to dyslipidemia, given that low-birth-weight offspring ex-
hibit defects in the expression of critical genes (eg, Cyclin
T2 and HNFa) involved with leptin secretion and insulin
sensitivity.64,65
35 The major factor influencing the inverse relation-
ship between low-birth-weight offspring and metabolic
disease in postpartum life is nutrition-induced acceler-
ated growth, which culminates with an earlier onset of
the symptoms of dyslipidemia and the metabolic syn-
40 drome, compared with offspring without catch-up
growth.66–69 Given that liver development is highly
compromised in IUGR pregnancies, babies born from
these pregnancies undergo the greatest catch-up growth
during postnatal life.60,61 Postpartum recovery in he-
45 patic growth is evident in SGA children who undergo
hypersomatotropism as early as day 4 of postnatal life
due to increased hepatic and circulating insulin growth
factor 1 (IGF-1).70 This is detrimental in the long term
given that low-birth-weight infants with rapid postnatal
50 growth exhibit a higher low-density lipoprotein/high-
density lipoprotein ratio, likely attributed to impaired
cholesterol homeostasis in the liver.71 Although future
noninvasive imaging studies are warranted to track liver
and adipose development in these IUGR infants from
55fetal life to adulthood, to date, animal models of mater-
nal undernutrition have shed great light into the molec-
ular (ie, epigenetic) mechanisms underlying the fetal
programming of dyslipidemia.
Animal models linking maternal undernutrition and
60dyslipidemia
Idiopathic IUGR due to placental insufficiency occurs in
approximately 8% of all pregnancies.72,73 Moreover, ma-
ternal undernutrition in pregnancy can also lead to
IUGR depending upon the timing (pre- vs postconcep-
65tion) and severity of the insult.66,74–77 To date, the use of
various nutritional models of IUGR (eg, uterine ligation,
maternal nutrient restriction, and maternal protein re-
striction) has expanded knowledge of the distinct contri-
butions of both the mother and fetus toward long-term
70metabolic deficits. Uterine ligation or ablation in rodent
pregnancy is an excellent model of idiopathic IUGR
given that placental insufficiency leads to decreases in
both oxygenation and substrate availability for the fetus
alone.78–80 This model leads to impaired birth weight
75and lower liver-to–body weight ratios, followed by dysli-
pidemia and T2D, which are carried into the F2 gener-
ation.81–85 These metabolic deficits exist, in part, due to
altered glucose transporter expression, impairment of
fatty-acid metabolism, increased glucocorticoid activity,
80augmented glucose production, and blunted insulin sup-
pression, all within the liver.81,83,86–88 It is noteworthy
that these rat offspring also exhibit decreased hepatic and
circulating insulin-like growth factor-1 (Igf-1), which is
critical for insulin function, glucose metabolism, and
85growth.89 In the guinea pig, uterine ablation manifests in
hepatic perisinusoidal or periportal fibrosis in postnatal
life concomitant with increased expression of profibro-
genic markers, including Smad4, Tgfb1, andMmp2.90
Maternal nutrient restriction (MNR) or materal
90protein restriction (MPR) models provide insight into
the contribution of maternal malnutrition alone on long-
term hepatic function and dyslipidemia. Similar to off-
spring in the uterine ligation model, MNR offspring are
compromised at birth, then experience rapid postnatal
95catch-up growth.75,91,92 However, in this model, the im-
pact of a decrease in both maternal and placental weight
during pregnancy must be taken into consideration.75,93
Sheep and rat studies have demonstrated that MNR leads
to higher hepatic lipid and glycogen content in the off-
100spring, manifesting in glucose intolerance and insulin
insensitivity.91,94 The impaired glucose tolerance in
MNR sheep offspring is also attributed, in part, to in-
creased circulating cortisol and augmented hepatic Pepck
expression.94 In contrast with uterine-ligated offspring,
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MNR offspring with catch-up growth exhibit increases in
Igf-1, which has been associated with decreased longevity
but not necessarily metabolic disease.91 Overall, although
maternal nutrient status may directly alter the expression
5 of the these hepatic genes via epigenetic mechanisms,
this may also occur indirectly, given that maternal under-
nutrition increases hypoxia in fetal metabolic (ie, liver,
kidney) organs.91,93,95
Finally, maternal low-protein diets and/or placental
10 insufficiency often lead to fetal deficiencies in amino
acids, which are critical for growth.96,97 Therefore, the
MPR model is a very distinct and relevant model to ex-
amine how reduced amino acids lead to asymmetric
IUGR, without any impact on maternal physiology (eg,
15 weight gain or food intake).62,98 Depending on the tim-
ing of protein restoration, MPR offspring display glu-
cose intolerance, visceral obesity, hypercholesterolemia,
and hypertension despite no differences in postnatal
food intake.98–104 The hypercholesterolemia exhibited
20 in MPR male offspring following catch-up growth was
attributed to silencing of Cyp7a1, the critical enzyme in
cholesterol metabolism.99 Interestingly, the expression
and activity of hepatic Cyp3a and Cyp2c11 was aug-
mented in these MPR offspring, implying that long-
25 term drug metabolism (ie, statins) could be influenced
by compromised fetal development.105 Because testos-
terone is a major substrate for Cyp3a and Cyp2c11
enzymes, this may also explain the lower circulating tes-
tosterone levels in MPR male offspring and, consequen-
30 tially, the long-term sexual dimorphism that exists in
this model.104 Similar to uterine-ligated offspring, MPR
offspring with catch-up growth have lower hepatic Igf-1
expression; however, this decrease is mainly attributed
to the effects of protein restriction during lactation.98
35 Collectively, the MPR model truly highlights the main
tenet of Barker’s “predictive adaptive response,” which
suggests that when there is no nutritional mismatch in
postnatal life, MPR offspring do not exhibit any altera-
tions to cholesterol catabolism, insulin sensitivity, or
40 drug metabolism later in life.99,100,105
Although human and animal studies have certainly
established strong links between maternal malnutrition
and metabolic deficits in the offspring, the origin of
IUGR and long-term dysmetabolism are not only linked
45 with a poor nutritional environment in utero. Certainly,
any disturbances in the maternal–fetal hormonal milieu
during pregnancy could influence the etiology of IUGR
and, more important, the long-term programming of
endocrine function, growth, and cardiovascular health.
50 GLUCOCORTICOID EXPOSURE AND ADULT HEALTH
Cortisol, the principal circulating glucocorticoid hor-
mone in humans, is essential for normal fetal
development and tissue maturation. One of the major
hypotheses to explain DOHaD is fetal glucocorticoid
55overexposure.106 This hypothesis is supported by sub-
stantial experimental data (in rodents and other species)
where manipulations that increase fetal glucocorticoid
exposure cause lower offspring birth weight and associ-
ated cardiovascular risk factors, including higher blood
60pressure and insulin resistance, as well as mental health
and cognitive problems, in later life.107 Indeed, early
studies suggested that the effects of maternal undernu-
trition are partly mediated by glucocorticoids. For ex-
ample, the hypertension induced in the offspring by a
65maternal low-protein diet is prevented by pharmacolog-
ical blockade of glucocorticoid biosynthesis and can be
reintroduced by replacement of corticosterone.108 Thus,
it is important to review recent data that may implicate
the influence of cortisol on specific pathways that may
70mediate disease risk, such as altered maternal cortisol
due to maternal stress and/or obesity.
In humans, available data also suggest that gluco-
corticoid programming occurs. Maternal treatment
with synthetic steroids in pregnancy is associated with
75lower birth weight and insulin resistance in young
adulthood.109 Higher endogenous maternal cortisol lev-
els measured in blood, saliva, urine, or amniotic fluid
have been linked to offspring lower birth weight or
shorter gestation at delivery.110 The differences in corti-
80sol are modest but have major influences on pregnancy
outcomes. In 1 study, a 2.6% greater salivary cortisol
level at wakening was associated with a 1-week shorten-
ing of pregnancy duration.111 However, the findings
may be confounded by timing of sample collection, ges-
85tational age at time of sample collection, and maternal
characteristics and are dependent on whether total cor-
tisol or free (bioavailable) cortisol is measured. For ex-
ample, in a large study of 2810 women, the association
between higher maternal serum cortisol measured in
90the early second trimester and lower birth weight was
only observed among women with morning cortisol
measurements, and the relationship attenuated after ad-
justment for confounding factors.112 Regardless, it is
clear that maternal cortisol levels do exert some influ-
95ence on fetal growth and pregnancy.
There is also increasing evidence that the adverse
effects of fetal glucocorticoid exposure extend well be-
yond fetal growth. Comparisons of siblings show that
those who were exposed to high cortisol in utero have
100lower IQ levels at age 7 years and complete 1 fewer year
of schooling.113,114 Such within-sibship comparisons are
less likely to be confounded by shared familial charac-
teristics, such as background socioeconomic character-
istics, than more standard observational epidemiology
105studies. Additionally, both endogenous maternal corti-
sol levels in pregnancy and use of exogenous antenatal
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steroids have been linked to changes in childhood brain
development and behavior.115,116 Prenatal exposure to
elevated maternal cortisol levels has also been linked
with increased cardiovascular risk factors in the off-
5 spring at age 42 years.117 The adult daughters of moth-
ers with the highest free cortisol tertile during the third
trimester of pregnancy versus daughters of mothers
with the lowest cortisol tertile had a 36.7% (95% confi-
dence interval [CI], 8.4%–72.5%) greater mean 10-year
10 coronary heart disease risk score, calculated using the
Framingham risk algorithm incorporating diabetes, sys-
tolic and diastolic blood pressure, total and high-
density lipoprotein cholesterol, smoking, age, and sex.
One possible mechanism explaining maternal glucocor-
15 ticoid levels and birth outcomes may be a perturbation
of the hypothalamic-pituitary-adrenal (HPA) axis.
The regulation of the maternal HPA axis undergoes
dramatic changes during pregnancy, with circulating
cortisol levels rising markedly to approximately 3-fold
20 nonpregnant levels by the third trimester.118 The fetus
is protected from high maternal glucocorticoid levels by
the placental barrier enzyme 11ß-hydroxysteroid dehy-
drogenase type 2 (HSD2), which converts active cortisol
to inactive cortisone. In animal models, manipulations
25 that reduce HSD2 activity (either pharmacological inhi-
bition, maternal low-protein diet, or genetic modifica-
tion to knock down HSD2) increase fetal exposure to
glucocorticoids, which results in lower birth weight.107
Placental HSD2 also appears to be a key player in hu-
30 man developmental origins of health and disease.
Children homozygous for mutations in hsd11b2 encod-
ing HSD2 have lower birth weight than their unaffected
or heterozygous siblings.119 Lower placental HSD2 ac-
tivity correlates with reduced birth weight in some (but
35 not all) human studies and higher blood pressure in 3-
year-olds who had a normal birth weight.120,121
Observational studies show that women who consume
large amounts of liquorice (which contains glycyrrhizin,
an HSD2 inhibitor) during pregnancy have a shorter
40 gestation.122 Intriguingly their children have increased
odds of attention-deficit-hyperactivity disorder behav-
iors, score lower on tests of IQ, and have poorer mem-
ory, and the girls enter puberty earlier.123 Direct
placental perfusion studies done immediately postpar-
45 tum show that liquorice derivatives allow substantially
increased passage of active cortisol from the maternal
circulation to the fetal circulation, suggesting fetal glu-
cocorticoid exposure as a mechanism underlying the
adverse offspring consequences of maternal liquorice
50 consumption in pregnancy.124 Importantly, placental
HSD2 is downregulated by other programming influen-
ces, including maternal malnutrition, inflammation, or
stress in rodent models and maternal stress in humans,
suggesting placental HSD2 activity may be a key
55mechanistic pathway underpinning programming.107,125
Studies using HSD2/ mice fed a maternal low-protein
diet tested whether reduced placental HSD2 activity was a
crucial link between the maternal environment (undernu-
trition) and adverse programming outcomes. The
60HSD2/ fetuses of mice fed a low-protein diet had re-
duced fetal weight compared with fetuses of mice fed a
control diet, indicating that the growth-restricting effects
of the maternal low-protein diet act in addition to any re-
duction in HSD2 activity, thereby refuting this as the sole
65mechanistic pathway.126
Although the focus of this review has been on ma-
ternal undernutrition and adverse fetal and infant out-
comes, the challenge facing the DOHaD field is
maternal obesity, with 1 in 5 women in Western socie-
70ties obese during the antenatal period. Epidemiological
studies show that offspring born to obese mothers have
an increased risk of premature death from cardiovascu-
lar events, increased cardiometabolic risk factors, and a
host of other health issues, including poorer neuropsy-
75chiatric and neurocognitive development and increased
susceptibility to asthma.127–130 No studies have investi-
gated whether this may be mediated by altered maternal
cortisol and/or placental HSD2 activity in obese preg-
nant women. Observational studies show maternal cor-
80tisol levels are lower in obese pregnant women and that
obese pregnant women have decreased HPA axis activ-
ity, as evidenced by lower corticotrophin-releasing hor-
mone (CRH) levels compared with normal-weight
women.112,131,132 Preliminary data suggest this may im-
85pact on outcomes. For example, in 1 study, CRH levels
at 28weeks were an independent predictor of gestation
at delivery in analyses adjusting for confounding factors
(a mean decrease in CRH of 0.25 pmol/L [95%CI,
0.45 to 0.043 pmol/L] for every 1-day increase in
90gestational age at delivery).131 This observation suggests
that adverse pregnancy outcomes may result not only
from high maternal cortisol levels and increased HPA
axis activity (as previously found in the animal studies
and existing human studies) but also from lower mater-
95nal cortisol levels and decreased HPA axis activity (as
observed in obese pregnant women). This suggests
there is an optimal glucocorticoid exposure for normal
fetal growth and gestation length: fetal glucocorticoid
overexposure associates with lower birth weight and
100preterm delivery, whereas underexposure associates
with higher birth weight and longer gestation at deliv-
ery. Both fetal glucocorticoid over- and underexposure
are associated with adverse consequences for offspring
health. Further studies are needed to test his hypothesis.
105Based on the studies reviewed, the available evi-
dence supports altered glucocorticoid action, sensitivity
and/or transfer to the fetus as a major endocrine path-
way linking fetal growth to later life disease.
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Dysregulation of this pathway occurs in both maternal
undernutrition and overnutrition impacting on fetal
glucocorticoid exposure and subsequent growth. The
molecular mechanisms underpinning altered glucocor-
5 ticoid exposure to fetal growth remain poorly under-
stood, but candidate processes are discussed in the next
section.
UNDERLYING MECHANISMS
To date, emerging animal and clinical studies are begin-
10 ning to elucidate how poor nutrition in utero or during
the first 2 years of life influences disease risk later in
life. These include epigenetic and transcriptional mech-
anisms, cellular stresses, metabolic adaptations, altera-
tions to the microbiome, and/or social determinants.
15 Some of these mechanisms (ie, epigentetic) are insti-
gated at the time of the perinatal insult, whereas other
mechanisms (ie, endoplasmic reticulum stress) play a
greater role to influence metabolic disease during post-
partum life (ie, during catch-up growth).99,100
20 Epigenetic mechanisms elucidate many of the long-
term effects of these perinatal insults given that they can
quickly influence gene expression in a tissue- and gene-
specific manner to adapt to suboptimal (eg, undernutri-
tion) windows of developmental plasticity. However,
25 these epigenetic changes can have long-lasting implica-
tions on gene expression in postnatal life, resulting in
metabolic disease. Mechanisms of epigenetic action in-
clude DNA methylation, post-translational histone
modifications, and microRNA-mediated repression.
30 IUGR offspring resulting from various degrees of ma-
ternal malnutrition and/or placental insufficiency may
exhibit different or similar metabolic deficits due to
global, tissue, or site-directed epigenetic modifications.
DNA methylation
35 The chromatin environment can be altered during peri-
natal life due to direct DNA methylation whereby
methyl groups are added to CpG sites on DNA by
members of the DNA methyltransferase family. Given
that the essential amino acid methionine provides a
40 critical donor to DNA methylation, it is not surprising
that alterations in dietary folate/folic acid (involved in
methionine metabolism and required for methylation
reactions) during perinatal life have a profound effect
on DNA methylation profiles and long-term gene
45 expression.133 In humans, adipose-derived stem cells
(ADSCs) from low-birth-weight adult men display in-
creased DNA methylation surrounding the promoter of
CYCLIN T2, which is attributed to impaired leptin
secretion.64 Moreover, IUGR infants exhibit hyperme-
50 thylation of the HNF4a gene, a nuclear receptor, which,
when impaired, leads to T2D.65,134 Lillycrop et al135,136
found that MPR in rats leads to decreased hepatic ex-
pression of DNA methyltransferase-1 and lower DNA
methylation surrounding the promoter of the glucocor-
55ticoid receptor (Gr), culminating in higher expression
of Gr in the offspring. Conversely, high levels of methyl
vitamins (eg, folate, vitamins B12 and B6) in rodent
pregnancy promotes DNA methylation of the leptin
promoter, contributing to obesity and insulin resistance
60in the offspring.133 It should be noted that undernutri-
tion does not always result in increased DNA methyla-
tion. In sheep, a maternal diet lower in amino acids led
to decreased DNA methylation surrounding the pro-
moter of insulin growth factor 2 receptor (Igf2r) in fetal
65white adipose tissue.137 In primate studies, baboon
MNR offspring exhibit decreased methylation of the
promoter of PCK1 concomitant with augmented
PEPCK expression, which is implicated in hyperglyce-
mia and T2D.93,138,139
70Maternal undernutrition leading to altered DNA
methylation can also have transgenerational consequen-
ces. For example, uterine ligation in pregnancy culmi-
nated in offspring with higher DNA methylation in the
promoter of hepatic Igf-1, which persists into the F2
75generation even if the F1 IUGR offspring are completely
nourished.84,140 Interestingly, supplementing the diet of
the F1 IUGR offspring with folic acid, choline, betaine,
vitamin B12, and other essential nutrients prevented the
hypermethylation of the Igf-1 promoter in the F2 gener-
80ation, alleviating the symptoms of the metabolic
syndrome.84
Post-translational histone modifications
Post-translational histone modification, a second major
epigenetic mechanism involved in fetal programming,
85influences the chromatin environment via methylation,
acetylation, phosphorylation, ubiquitination, and/or
ADP-ribosylation of histones.141 In general, euchroma-
tin is associated with histones, which are acetylated on
specific residues (eg, K9 and K14 of histone H3),
90whereas heterochromatin contains predominately
hypoacetylated and/or methylated histones.142 These
histone modifications occur and can be sustained by a
diverse range of histone-modifying enzymes whose ex-
pression levels may also be influenced by external envi-
95ronmental insults (eg, low nutrients) during critical
perinatal windows of development.142
Rat models have demonstrated that uterine liga-
tion, maternal hypoxia, and MPR lead to post-transla-
tional histone modifications and altered hepatic and
100pancreatic function in the offspring.99,103,143,144 As pre-
viously mentioned, MPR-induced IUGR rat male off-
spring exhibit hypercholesterolemia concomitant with a
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decrease in postnatal Cyp7a1 expression, in both the short
and long term.99 This was associated with enhanced tri-
methylation of histone H3 (lysine 9) and suppressed acety-
lation of histone H3 (Lysine 9, 14), all markers of
5 chromatin silencing, within the LXRE region of the
Cyp7a1 promoter from 3 weeks to 4 months of postnatal
life.99 In contrast, 4-month-old MPR female offspring did
not exhibit changes in histone modifications or altered
cholesterol levels.99 The trigger of these histone modifica-
10 tions in fetal life are due, in part, to MPR-mediated
decreases in lysine demethylases involved in removing tri-
methyl groups of histone H3 (lysine 9). Maternal protein
restriction has also led to silencing of the promoter of liver
X receptor (Lxra) in the liver at 4 months of age due to
15 decreased histone H3 acetylation (lysine 9, 14), resulting
in increased hepatic gluconeogenesis.103 In a model of ma-
ternal hypoxia (eg, 12% oxygen) in rodent pregnancy lead-
ing to decreased maternal food intake and IUGR, the
12-month-old IUGR male offspring displayed hypoglyce-
20 mia concomitant with increased histone H3 trimethyla-
tion (lysine 9) of the hepatic G6Pase promoter.144
MicroRNAs
MicroRNAs (miRNAs) can also play a key role in the
fetal programming of metabolic disease. MicroRNAs
25 are short, noncoding RNA molecules 20–25 nucleotides
in length that regulate gene expression via degradation
of mRNA species and/or repression of translation.145,146
Because they can bind to 3’-UTR with partial sequence
homology to induce cleavage or repression of produc-
30 tive translation, it is well established that a single
miRNA may have numerous targets in the genome.147
Conversely, given the nature of miRNA targeting, a sin-
gle mRNA transcript can theoretically be targeted by
several miRNAs.147
35 In low-birth-weight humans and the offspring of
undernourished rats, higher adipose miR-483–3p levels
have been associated with decreased growth differentia-
tion factor-3 (gdf3), leading to enhanced lipotoxicity,
decreased lipid storage, and higher insulin resistance.148
40 Moreover, MPR during pregnancy and lactation has
been demonstrated to increase the hepatic expression of
the entire miR-29 family in postnatal life, which silences
the expression of Igf-1, which is believed to contribute
to decreased growth.98 Interestingly, restoration of ma-
45 ternal dietary proteins in MPR offspring at birth pre-
vented miR-29 repression of Igf-1.98 In the guinea pig
uterine ligation model, undernutrition in utero sup-
pressed miR-146a expression in 5-month-old offspring,
concomitant with an increase in miR-146a’s target pro-
50 fibrotic gene, smad4.90 Elegant rodent studies have
demonstrated that individual changes in maternal die-
tary lipids (ie, soybean, olive oil, fish oil, linseed, or
palm oil) can have differential effects on
programming the long-term expression of miRNAs in
55metabolic tissues.149 Moreover, the dietary lipid modifi-
cations that led to alterations in the long-term
expression of these miRNAs were pregnancy- and
tissue-specific (eg, the liver).149
Indirect effect of postnatal catch-up growth in
60mediating long-term metabolic dysfunction
In addition to changes in the epigenome initiated by
insults during perinatal life, postnatal catch-up growth
in undernourished offspring also plays a major role in
exacerbating the metabolic outcomes in low-birth-
65weight children.66–69 Given that the undernourished
neonatal liver undergoes major postnatal catch-up
growth, it is very likely that the stress of active hepato-
cyte replication and growth during this period may lead
to greater detrimental metabolic deficits, which only
70arise after this window of nutrient recovery. A major
mechanism likely involved in this rapid growth–
triggered process is endoplasmic reticulum (ER) stress.
Endoplasmic reticulum stress ensues when ER homeo-
stasis is compromised, leading to luminal accumulation
75of misfolded or unfolded proteins.100 Endoplasmic re-
ticulum stress can be triggered by alterations in amino
acids, hypoxia, increase in lipid load, impaired disulfide
bond formation, compromised Ca2þ homeostasis, de-
creased N-linked glycosylation, and oxidative stress. In
80response to ER stress, the unfolded protein response
tries to alleviate the ER by increasing the expression of
chaperone proteins involved in refolding misfolded
proteins and/or attenuating protein translation.
However, if ER stress persists, apoptosis is initiated,
85leading to alterations in gene expression and cell func-
tion. In 5-month-old MPR offspring with postnatal
catch-up growth (due to restoration of proteins at
weaning), there is augmented hepatic ER stress attrib-
uted to impaired insulin sensitivity.100
90In contrast, hepatic ER stress concomitant with im-
paired insulin signaling is not evident in fetal life or in
5-month-old MPR offspring that do not undergo catch-
up growth.100 This would suggest that the low-protein
diet itself does not play a direct role in instigating ER
95stress, but rather, the ER stress is caused by the catch-
up growth that results from the nutritional mismatch
after weaning. In a rat model of perinatal nicotine expo-
sure that led to IUGR offspring and long-term dyslipi-
demia, ER stress was also evident in the adipose tissue
100after postnatal catch-up growth.150,151 Higher oxidative
stress, lipid overload, and/or impaired disulfide bond
formation likely triggers the cascade that leads to
chronic ER stress when there is a nutritional mismatch
in postnatal life.83,85 Endoplasmic reticulum stress in
10 Nutrition ReviewsVR Vol. 00(0):1–20
these IUGR offspring with catch-up growth could also
alter epigenetic events, such as alterations in
microRNAs. For example, activation of ER stress can
induce miR-29a.152 It is noteworthy that miR-29a is in-
5 creased in MPR offspring with both catch-up growth
and ER stress, concomitant with suppression of both of
its target genes, Igf-1 and pAkt-1 (Ser473).98,100
Metabolic adaptations following growth retardation
Studies of potential metabolic mechanisms to explain
10 the link between in utero or postnatal undernutrition
and adult health have focused on specific components
of energy expenditure, such as resting metabolic rate
(RMR) or substrate oxidation, because certain meta-
bolic adaptations may increase the risk for adiposity
15 later in life. Two studies found no differences in RMR
in stunted children compared with normal-height
children.153–155 However, others found a lower rate of
energy expenditure in growth-retarded children com-
pared with normal-height children.156,157 As noted pre-
20 viously, differences in the results of studies of body
composition or energy metabolism can often be attrib-
uted to differences in methodologies or statistical analy-
ses. For example, the 2 cited studies that show
metabolic differences used ratios for energy metabolism
25 per unit of body composition rather than linear regres-
sion analysis, which would be the more appropriate sta-
tistical approach.
Studies of substrate oxidation are more consistent
than those of energy expenditure in that a number of
30 studies have found metabolic adaptations associated
with poor growth in utero or during early childhood.
One of the first studies of metabolic adaptations and
poor growth studied a cohort of children in Brazil and
found that stunted children oxidized fat at a lower rate
35 than normal-height children from the same shanty-
towns of S~ao Paulo, Brazil.158 Adult men from the
Hertfordshire cohort who were born small compared
with others from the cohort born with a higher birth
weight had a lower rate of daily fat oxidation.159
40 Additionally, adults from the Buryat communities in
southern Siberia who experienced growth retardation
following the fall of the Soviet Union and were shorter
than their peers had a lower rate of fat oxidation.160
Finally, North Korean children who were either stunted
45 or short for age had a significantly lower rate of fat oxi-
dation (P< 0.05) than North Korean children who were
not growth retarded.161 These consistent findings across
cultural and genetic differences suggest that poor
growth, either in utero or during childhood, results in a
50 metabolic adaptation that favors fat storage and pro-
motes excess adiposity under the right environmental
conditions. There are a number of potential
explanations for these results, but they remain difficult
to confirm given the ethical aspects of studying poor
55growth as it occurs. However, studies of large mammals
may provide evidence for potential mechanisms.
With regard to metabolism of large mammals ex-
posed to energy restriction, 1 study involved pigs born
with low (L) or normal (N) birth weight that were sub-
60sequently fed either ad libitum or exposed to further en-
ergy restriction (R) following weaning and found that
the L pigs had significantly lower fat oxidation
(P¼ 0.005) than the N pigs.162 Moreover, the rate of fat
oxidation was 50% lower in the LR pigs than in the NR
65pigs. Mechanisms of metabolic adaptions following
energy restriction based on results from both pig and
human studies may be supported by a study in protein-
restricted pigs, in which those pigs fed a 14% protein
diet increased expression of lipogenic genes (eg, FAS,
70PPARc, and FABP4) compared with pigs fed a 20% pro-
tein diet.163 Additionally, the pigs on the low-protein
diet had a lower expression of lipolytic genes than those
on the normal-protein diet. Still, studies of sheep sug-
gest that energy restriction alters substrate metabolism
75in a tissue-specific manner and may favor carbohydrate
metabolism.164,165 Nonetheless, given that the research
cited above showed that poor growth is associated with
less lean body mass166 and poor bone development,38
body composition compartments that are metabolically
80active, such adaptations that favor carbohydrate metab-
olism seem logical. At the same time, recent research
discussed below suggests that changes in the micro-
biome or specific nutrient deficiencies (B vitamins) may
also alter nutrient delivery or availability in ways that al-
85ter or interfere with normal metabolic pathways and
could result in changes in substrate oxidation.
Role of the microbiome as a mediator between poor
growth and chronic disease
Recently, the microbiome has been shown to differ be-
90tween humans who are normal weight and those who
are obese,167 an observation that has generated novel hy-
potheses related to the role of the microbiome and fac-
tors that influence gut health in the growth and
development of children. A great proportion of under-
95nourished children live in communities with poor sanita-
tion where the risk of intestinal infections is high and
access to adequate nutrition is limited.168 Persistent diar-
rhea is known to cause alterations in intestinal integrity,
decrease the absorption of nutrients, cause inflammation,
100and increase the risk for other enteropathic conditions
that promote undernutrition.169 Growth faltering is sure
to occur if repeated intestinal infections occur and poor
nutrition prevents complete recovery of intestinal
changes due to diarrhea, both of which may alter the gut
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microbiome. What is not well known is whether changes
in the microbiome are a result of undernutrition and/or
what role the microbiome may have on the development
of pathogenic phenotypes, such as obesity or metabolic
5 adaptations to undernutrition.
Undernourished children have a less diverse gut
microbiota than healthy children.170 More importantly,
it was recently reported that children suffering from sub-
acute malnutrition had an “immature” microbiota com-
10 pared with a standard curve developed from healthy
children living in the same part of Bangladesh.171 An im-
portant study of growth and microbiome found that
microbiota transplanted from healthy or undernourished
children to healthy mice resulted in normal or impaired
15 growth, respectively.172 Recently, an interesting analysis
of common bacteria found in the human microbiome
was presented in relation to the biosynthesis of B vita-
mins, and it was reported that riboflavin and niacin are
among the vitamins most commonly synthesized by the
20 human microbiota.173 This finding is of particular im-
portance because alterations in the bacterial milieu can
plausibly alter the availability of key micronutrients in-
volved in the tricarboxylic acid cycle and ATP synthesis,
potentially altering energy metabolism. Although clinical
25 studies to address this question are lacking, 1 study of
maternal vitamin status and offspring adiposity showed
that children born to women with low vitamin B12 status
had greater adiposity and insulin resistance compared
with those born to women with normal B12 status.
174
30 Thus, maternal B vitamin deficiencies may play a central
role in adult body composition and chronic disease risk
of offspring, as discussed in a review by Finer et al.175
Moreover, the authors outline the impact that B vitamin
deficiencies in utero have on 1-carbon metabolism,
35 which could have downstream effects on metabolic pro-
cesses, including carbohydrate and lipid metabolism, as
well as methylation patterns of key genes involved in en-
ergy metabolism. Therefore, it is conceivable that micro-
biome disruptions or alterations may contribute to, or
40 perpetuate, metabolic adaptations as discussed above,
lending support to the notion that environmental condi-
tions play a leading or complementary role in growth
and the development of adult disease.
Social and economic determinants of growth and role
45 in developmental origins of health and disease
Clearly a number of physiological mechanisms plausibly
link poor growth early in life to chronic disease develop-
ment in adulthood. At the same time, an area that often
receives limited attention is the socioeconomic and envi-
50 ronmental conditions in which children with poor
growth develop. These areas are important to consider
given that various social and environmental factors, such
as education, income, access to food, and sanitation, play
direct roles in fetal growth, nutrient availability, and ma-
55ternal health. Data on the interaction between biological
and social factors that influence growth and health are
important to consider given the broader goal of improv-
ing health in all parts of the world.
Studying biological processes within the context of
60economic changes reveals subtle influences that may
precede poor nutrition or impede adequate dietary in-
take, both of which influence subsequent growth and
development. From the Bt20 cohort, improving socio-
economic status was determined to be protective
65against higher systolic blood pressure, independent of
size at birth.20 In addition, higher levels of social sup-
port and income were both found to be predictors of
bone mineral content, even after adjusting for body
composition and pubertal development.21 Exposure to
70the Chinese famine and living in higher-income areas
were independently associated with an increased risk of
T2D, suggesting that prosperity may exacerbate the risk
for chronic disease formerly thought to be only attribut-
able to famine exposure.176 Such interactions are most
75apparent in a study by Li et al177 in which in utero fam-
ine exposure increased the risk of T2D, yet those adults
exposed to the famine who ate a Western diet were
even more likely to have T2D compared with those who
ate a traditional diet, clearly illustrating the intricate in-
80teraction between in utero and environmental expo-
sures in regards to chronic disease development.
Although these studies focus on birth weight, a
number of studies of postnatal growth retardation have
shown the impact of socioeconomic status on risk and/
85or recovery from stunting as well as long-term effects of
stunting on human capital. In South Africa, a higher
birth weight was protective against stunting in boys and
girls, but higher maternal education was protective in
girls, whereas higher socioeconomic status was protec-
90tive for boys.23 As discussed earlier, even children who
recover from stunting by age 5 years face considerable
cognitive challenges compared with children of normal
height, including challenges as severe as children with
stunting remaining stunted.23 A multicountry study of
95growth and human capital found that children who are
born with a higher birth weight or have greater gain in
height by age 2 years attained a higher level of school-
ing, an amount estimated to increase adult income by
5%.2 This result is even more pronounced when the
100same data were used to evaluate broad aspects of human
capital, including economic productivity, and found
that height-for-age at 2 years was the best predictor of
overall human capital.
Although the focus of this review has been on po-
105tential physiological mechanisms that explain how early
growth influences adult health and disease, it remains
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important for investigators to appreciate and encourage
multidisciplinary research of DOHaD. Given that poor
growth has a considerable impact on both economic
and human conditions in many countries, but mostly in
5 lower-income countries where the prevalence of under-
nutrition is still high, the social cost of this research is
as important as the scientific discoveries.
INTEGRATION OF MECHANISMS AND FUTURE
DIRECTIONS
10 The mechanisms discussed in this review highlight the
complexity of studying DOHaD in the context of deter-
mining how poor nutrition during critical periods of
development may increase the risk of chronic disease
later in life. A PubMed search of research related to
15 DOHaD, ranging from epigenetic studies in rodents to
human interventions, revealed areas where abundant or
limited research has been published, including animal
models, species, nutritional exposure, outcome, or in-
tervention. This search was not performed as part of a
20 critical meta-analysis of the topic, but it does identify
areas where more research needs to be focused (see
Figure 1). A file with the specific numbers of publica-
tions by area is provided (see DOHaD Publication
Frequency Summary in the Supporting Information on-
25line), and access to search terms and results is available
from the authors.
However, although not all potential mechanisms
were discussed in the present review, the collective
results from rodent, large animal, nonhuman primate,
30and human studies reveal potential integrated mecha-
nisms that underlie DOHaD. For example, changes in
fetal cortisol metabolism following maternal exposure
to glucocorticoids may impact body composition, as
found in several studies of growth retardation and adult
35fat distribution.39,178–180 Likewise, the epigenetic effects
caused by undernutrition (ie, MPR) very likely influ-
ence lipid metabolism in an indirect manner by altering
the expression of PPARc and its downstream lipogenic
targets in adipose and hepatic tissue.88,181 Studies also
40strongly demonstrate how postnatal catch-up growth
might exacerbate IUGR-induced metabolic deficits via
the integration of several mechanisms. Indeed, catch-up
growth of undernourished IUGR rodents leads to long-
term hepatic ER stress and alterations in miRNAs, cul-
45minating in impaired endocrine signaling (ie, Igf-1,
pAkt1 [Ser473]),98,100 which is noteworthy because acti-
vation of ER stress increases the expression of
miRNAs.152,182 Of course, such extrapolations are open
HUMANS
NON-HUMAN
PRIMATES
SHEEP
PIGS
RODENTS
Figure 1 Research density map of areas where abundant or limited resarch on developmental origins of health and disease have
been conducted and published. The x and y axes depict species and areas of research, respectively, with density of publications depicted
by colored circles. Green indicates 50–100 publications, blue indicates 20–49 publications, yellow indicates 1–19 publications, and white indi-
cates no publications. Abbreviations: HPA, hypothalamic-pituitary-adrenal; miRNA, microRNA.
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to debate, and such debates are encouraged to inform
research and policy agendas. What remains at the crux
of these discussions is the differential and sometimes
competing impact of various forms of undernutrition
5 during different windows of tissue and organismal
development.
As is often reported, the survivors of the Dutch
famine winter developed different chronic diseases pri-
marily based on when their mothers experienced the
10 famine—specifically whether it occurred during early,
middle, or late pregnancy.32,183–186 Moreover, Sohi
et al.98,100,103,105 have published a number of studies on
the differential effects of long-term hepatic cholesterol,
gluconeogenesis, Igf-1, and drug metabolism in relation
15 to the specific type of energy/nutrient restriction and
timing of undernutrition. Regardless of the precise epi-
genetic, biochemical, or physiological outcomes found
by the thousands of studies on DOHaD, there is still a
general lack of consensus on how these mechanisms in-
20 tegrate with the original tenet of Barker‘s predictive
adaptive response hypothesis: that a thrifty phenotype
occurs when there is a mismatch in the predictive envi-
ronment between perinatal and postnatal life.187 Such
consensus may remain elusive given the challenges
25 noted. Moving forward, it is imperative that gaps in re-
search be highlighted to facilitate the proposal of more
general mechanisms. Even more important is the poten-
tial for existing hypotheses to be used to formulate safe
interventions that can prevent or ameliorate chronic
30 diseases related to perinatal undernutrition.
Moving forward—the efficacy of early life
interventions
Over the last few decades, clinical studies and animal
models have established strong links between an under-
35 nourished in utero environment and long-term meta-
bolic disease, but additional studies are warranted to
identify safe and efficacious interventions in early life to
ameliorate or prevent these metabolic deficits in low
birth-weight offspring. Regardless of the species, the de-
40 veloping organism is subject to windows of tissue plas-
ticity during pregnancy and in early life, and this
plasticity can be modified by external environmental
cues. These cues can consist of alterations in nutrition,
the microbiome, and/or the hormonal milieu.
45 From a nutrition standpoint, several studies have
investigated the ability of vitamins, folic acid, lipids,
and proteins to ameliorate the adverse effects of under-
nutrition on metabolic disease. In a maternal diabetes
model of IUGR in rodents, supplementation with vita-
50 mins C and E in pregnancy prevented decreases in fetal
liver weight and hepatic lipid peroxidation.188 Given its
role as a methyl donor for DNA methylation, folic acid
shows promise in reversing some of the epigenetic
mechanisms associated with undernutrition. Lillycrop
55et al135,189 demonstrated that administration of folic
acid (5 mg/g diet) during MPR pregnancy prevented
decreases in DNA methylation to the promoters of he-
patic PPARa and GR and subsequently diminished their
expression in early life with widespread, long-term
60effects in the adult liver. The timing and dose of folic
acid appear to be critical given that the periconceptional
intake of folic acid (400 mg/d) led to an increase in DNA
methylation of hepatic Igf-2 and, subsequently, low
birth weight.190 As mentioned previously, alterations in
65maternal dietary lipids can have differential effects on
the long-term expression of miRs and ultimately
insulin sensitivity in adipose and liver tissue.149,191
Furthermore, the addition of multiple nutrients (ie, folic
acid, vitamin B12) to the diet of undernourished off-
70spring can exert multigenerational effects, as shown by
the lack of impairments in hepatic and lipid homeosta-
sis in an F2 generation given supplements compared
with F2 offspring who were not given nutrient sup-
plementation.84 With regard to protein supplementa-
75tion in IUGR offspring, the beneficial effects appears to
be very promoter- and time-specific. In rats, full resto-
ration of maternal proteins at birth prevents long-term
decreases in hepatic cholesterol metabolism (eg,
Cyp7a1) and Igf-1 but leads to greater expression of
80genes involved in gluconeogenesis (eg, G6Pase and 11b-
HSD1).98,99,103 Moreover, administration of meat-
sourced amino acids (eg, 2.5% taurine) during gestation
and the first weeks of neonatal life led to restoration of
b cell mass in MPR offspring, which was attributed to
85normalization of DNA synthesis, apoptosis, and fetal is-
let vasculogenesis.192,193 These studies illustrate the
complexity of the relationship between the timing of
nutritional interventions and the plasticity of organ-
specific development, factors that are pertinent to
90designing interventions in human pregnancy. A system-
atic review of studies examining the long-term health
benefits in children exposed to maternal antenatal mul-
tiple micronutrient supplementation found no evidence
that, compared with iron and folic acid supplementa-
95tion, routine maternal antenatal multiple micronutrient
supplementation improved childhood survival, growth,
body composition, blood pressure, respiratory, or cog-
nitive outcomes.194 The authors concluded: “We rec-
ommend follow-up studies in more of the multiple
100micronutrient trials. Further research into biological
mechanisms by which an early advantage could be at-
tenuated will help in our understanding of the interven-
tion and in designing future trials” (p 181).194
As a complement to nutritional interventions, al-
105tering the hormonal milieu could also be very promis-
ing for reversing the adverse effects of undernutrition
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during pregnancy on metabolism in postnatal life. One
of the best examples is with the use of the glucagon-like
peptide-1 (Glp-1) analog, Exendin-4 (Ex-4). Neonatal
administration of Ex-4 to uterine-ligated IUGR rodent
5 offspring prevented the long-term development of he-
patic oxidative stress and insulin resistance.83
Moreover, it exerted beneficial effects to pancreatic b
cell function through increases in the expression of
Pdx-1.195 However, in sheep, neonatal Ex-4 administra-
10 tion in IUGR offspring did not improve insulin sensi-
tivity, likely because of greater tissue (eg, pancreas)
maturity at birth in this species.196,197 Translation of
such studies into human interventions is challenging
because the Glp-1 class of drugs is not licensed for use
15 during pregnancy. However, as an alternative approach
to improve insulin sensitivity, therapy with metformin
(a drug that is widely used in pregnancy and approved
for use by the United Kingdom National Institute for
Health and Care Excellence for treatment of women
20 with gestational diabetes) in early life has also been effi-
cacious in low-birth-weight individuals. In low-birth-
weight prepubertal girls, treatment with metformin for
4 years reduced insulin resistance, dyslipidemia, and
hyperandrogenism compared with controls.198 Other
25 clinical studies have demonstrated that only the combi-
nation of exercise and metformin in obese adolescents,
regardless of birth weight, decreases BMI and percent-
age body fat.199,200 In IUGR rats, postnatal treatment
with metformin diminishes the upregulation of hepatic
30 Gr normally associated with obesity and glucose intoler-
ance in these offspring.201 Two randomized controlled
trials that tested an intervention with metformin to im-
prove insulin sensitivity in obese pregnant women dem-
onstrated no impact on infant birth weight, although
35 infant ponderal index tended to be improved, suggest-
ing a potential beneficial effect of the intervention.202,203
The late timing of the intervention in the second
trimester when the fetal growth trajectory is already
established may have impacted on the outcomes, but
40 follow-up of the children is warranted, particularly to
establish whether there are any potential benefits of
metformin intervention in pregnancy on infant body
composition, as proposed in the MIG-TOFU study.204
Targeting nuclear receptors may have a more sus-
45 tained impact, given their widespread roles in influencing
endocrine and metabolic function. Female IUGR offspring
treated with agonists to the lipid-sensing nuclear receptor
PPARc showed long-term insulin-sensitizing effects, al-
though hypoglycemia was also exhibited.181 Given the role
50 of the liver X receptor (LXRa) in regulating cholesterol,
glucose, and fatty-acid homeostasis, altering LXR activity
in early life could impair several symptoms of the meta-
bolic syndrome. A pilot study using the LXR agonist
(GW3695) during neonatal life (postnatal day 5–15) in
55MPR offspring led to decreased total cholesterol levels
concomitant with increased LXRa and Cyp7a1 by 3 weeks
of age, but the long-term effects remain unclear.205
Finally, the use of prebiotics and probiotics to com-
bat undernutrition and promote healthy growth is con-
60tinuing to gain substantial research and policy attention,
such that a number of systematic reviews on the topic
have been published.206–208 Briefly, in 1 study of under-
nourished children in India, providing probiotic- and
prebiotic-fortified milk resulted in a 13–g/year greater
65gain in weight compared with the control children.209
Saran et al210 reported that stunted children who re-
ceived probiotic treatment for 6 months gained nearly
1.5 cm more in length during treatment and had fewer
reported cases of diarrhea compared with children who
70received standard isocaloric dietary treatments. Infants
in China who were undernourished and received probi-
otic treatments using yogurt gained almost 0.5 kg more
in weight over 9 months compared with control child-
ren.211 In addition, the children in the treatment group
75had a greater increase in HAZ by the end of the 9-month
treatment (0.123 vs 0.077; P< 0.01). What is not well un-
derstood is precisely how such treatments improve
growth, be it through increased nutrient availability, re-
duced intestinal infections, or reduced gastric permeabil-
80ity. Also, it is unclear whether specific strains of bacteria
or whether fermented foods that may contain other
strains or nutrients are most effective in supporting
growth in undernourished children. Thus, improving re-
search in this area should focus on integrated and com-
85prehensive assessment of metabolic parameters as well
as markers of gastrointestinal health to better under-
stand the mechanisms through which probiotics support
growth and health in undernourished children.212
Figure 2 summarizes the known neonatal interventions.
90Regardless of the success of particular intervention
strategies in animal models, caution must be approached
in assessing their overall efficacy. The efficacy of the in-
tervention is influenced by its duration with respect to
organ (prenatal vs postnatal) development in a species-
95specific manner. Moreover, the impact of the interven-
tion on epigenetic processes must also be considered to
determine its long-term sustainability (i.e., from neonatal
life to adulthood, and/or transgenerational) and specific-
ity (i.e., global vs promoter specific). For the time being,
100the safest approach may be to focus on general dietary
interventions to reduce the rate of catch-up growth in
IUGR offspring and the indirect burden it exerts on or-
gan development and long-term function.
CONCLUSION
105The concept of DOHaD was initially met with a great
deal of skepticism, but as studies began to show findings
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similar to those of the Dutch famine and Hertfordshire
cohorts, attention began to shift from epidemiological
associations toward physiological mechanisms. With
the advent of epigenetics, new and exciting possible
5 mechanisms are being explored and new clinical and
cohort studies are being developed to determine poten-
tial endocrine responses to undernutrition. As
reviewed, particular adaptations following exposure to
undernutrition vary according to the timing of the un-
10 dernutrition, degree of maternal stress, and a number of
social or economic factors. Clearly, the study design and
sample, be it rodent, large mammal, or human, limit the
implications of outcomes studied, whether it is response in
the HPA axis, metabolic profiles, microbiome, or
15miRNAs. The challenge for the future of DOHaD research
will be to develop cohort studies that use new technologies
to test hypotheses based on mechanisms proposed by ani-
mal studies. It will also remain important to improve the
overall understanding of how to moderate disease risk in
20populations with a high prevalence of undernutrition.
Above all, research agendas and policies must support
lower-income countries that continue to face economic
and nutrition challenges and are most at risk for both the
health and economic implications of DOHaD.
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